Home > Boards > US Listed > Biotechs > Brooklyn ImmunoTherapeutics Inc (BTX)

Ran to 80 few weeks ago. > gene

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
crudeoil24 Member Profile
Member Level 
Followed By 707
Posts 47,393
Boards Moderated 8
Alias Born 12/12/04
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/22/2021 4:57:58 PM
Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical Officer GlobeNewswire Inc. - 9/22/2021 10:07:32 AM
Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from September 20, 2021 GlobeNewswire Inc. - 9/21/2021 8:30:00 AM
Factor Bioscience Celebrates 10th Anniversary with Grand Opening of ISO Class 7 Cleanroom Facility in Cambridge, Massachusetts PR Newswire (US) - 9/15/2021 8:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2021 7:01:22 AM
Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Monday, September 20, 2021, at 4:30 PM ET GlobeNewswire Inc. - 9/13/2021 8:00:00 AM
Brooklyn ImmunoTherapeutics to Participate in Grand Opening of Cambridge-Based mRNA Cleanroom Facility Shared with Factor Bioscience GlobeNewswire Inc. - 9/9/2021 8:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/27/2021 5:46:47 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/20/2021 4:46:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/20/2021 4:46:05 PM
Brooklyn ImmunoTherapeutics Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum GlobeNewswire Inc. - 8/20/2021 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/20/2021 1:40:41 PM
Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from August 19, 2021 GlobeNewswire Inc. - 8/20/2021 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/17/2021 5:29:58 PM
Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Thursday, August 19, 2021 at 4:30 PM ET GlobeNewswire Inc. - 8/16/2021 4:15:00 PM
Brooklyn ImmunoTherapeutics Announces Second Quarter 2021 Financial Results GlobeNewswire Inc. - 8/16/2021 7:00:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/13/2021 5:06:59 PM
Brooklyn ImmunoTherapeutics to Present at the SNN Virtual Investor Conference on August 18, 2021 GlobeNewswire Inc. - 8/13/2021 2:21:57 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/26/2021 4:06:21 PM
Brooklyn Immuno Reports Inducement Grants GlobeNewswire Inc. - 7/23/2021 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2021 4:06:50 PM
Brooklyn ImmunoTherapeutics completes acquisition of Novellus Therapeutics Seeking Alpha - 7/19/2021 10:22:43 AM
Brooklyn ImmunoTherapeutics Completes Acquisition of Novellus Therapeutics GlobeNewswire Inc. - 7/19/2021 8:00:00 AM
Brooklyn ImmunoTherapeutics Welcomes Jay Sial as Chief Administrative Officer GlobeNewswire Inc. - 7/13/2021 8:15:00 AM
Brooklyn ImmunoTherapeutics to Present at the Access to Giving Virtual Investor Conference on July 15, 2021 GlobeNewswire Inc. - 7/12/2021 8:15:00 AM
crudeoil24 Member Level  Monday, 05/24/21 03:43:57 PM
Re: [SMART MONEY] post# 284
Post # of 297 
Ran to 80 few weeks ago. > gene editing is the latest medical technology paving the way for solutions to various diseases.

BTX

New York Yankees and Duke Basketball
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences